Overview
The purpose of this study is to test and evaluate novel treatment delivery of ECAP-controlled closed loop SCS through the incorporation of new software and/or hardware features for patients with the Evoke System.
Eligibility
Inclusion Criteria:
-
- Subject has undergone trial implant or is planning to be implanted with the Evoke System within its approved indication.
-
2. Subject is willing and capable of giving informed consent and able to comply
with study-related requirements.
Exclusion Criteria:
N/A